Testing effectiveness (Phase 2)Ended earlyNCT02075463
What this trial is testing
Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia
Who this might be right for
AnemiaAnaemia
GlaxoSmithKline 15